Body Mass Index and Long-Term Follow-Up Outcomes in Patients With Acute Myocardial Infarction by the Median of Non-HDL Cholesterol: Results From an Observational Cohort Study in China

Background: The association between obesity, non-HDL cholesterol, and clinical outcomes in subjects with acute myocardial infarction (AMI) undergoing percutaneous coronary intervention (PCI) is incompletely understood. The aim of this investigation was to explore the association between body mass in...

Full description

Bibliographic Details
Main Authors: Hui Gao, Aidong Shen, Hui Chen, Hongwei Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-10-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2021.750670/full
_version_ 1818682745409241088
author Hui Gao
Aidong Shen
Hui Chen
Hongwei Li
Hongwei Li
Hongwei Li
author_facet Hui Gao
Aidong Shen
Hui Chen
Hongwei Li
Hongwei Li
Hongwei Li
author_sort Hui Gao
collection DOAJ
description Background: The association between obesity, non-HDL cholesterol, and clinical outcomes in subjects with acute myocardial infarction (AMI) undergoing percutaneous coronary intervention (PCI) is incompletely understood. The aim of this investigation was to explore the association between body mass index (BMI), non-high density lipoprotein (non-HDL) cholesterol, and long-term follow-up prognosis.Methods: This present study used data obtained by the Cardiovascular Center of Beijing Friendship Hospital Database Bank. We identified 3,780 consecutive AMI populations aged 25–93 years from 2013 to 2020. Participants were categorized as normal weight (18.5 ≤ BMI <22.9 kg/m2), overweight (23.0 ≤ BMI <24.9 kg/m2), obese class I (25.0 ≤ BMI <29.9 kg/m2), and obese class II (BMI ≥ 30.0 kg/m2). The endpoint of interest was cardiovascular (CV) death, all-cause death, myocardial infarction (MI), stroke, unplanned revascularization, and cardiac hospitalization.Results:Participants with higher BMI were younger and more likely to be males compared with lower BMI groups. Elevated non-HDL cholesterol was present in 8.7, 11.0, 24.3, and 5.9% of the normal, overweight, obese class I, and obese class II groups, respectively. After multivariate adjustment, compared to normal-weight participants with decreased non-HDL cholesterol (reference group), obese participants with and without elevated non-HDL cholesterol had a lower risk of mortality (with obese class I and elevated non-HDL cholesterol: hazard ratio [HR] 0.44, 95% confidence interval [CI] 0.28–0.67; with obese class I and decreased non-HDL cholesterol: HR, 0.68, 95% CI, 0.47–0.98; with obese class II and elevated non-HDL cholesterol: HR, 0.42, 95% CI, 0.20–0.87; with obese class II and decreased non-HDL cholesterol: HR, 0.35, 95% CI, 0.16–0.72).Conclusion: In AMI participants performing with PCI, obesity had a better long-term prognosis which probably unaffected by the level of non-HDL cholesterol.
first_indexed 2024-12-17T10:23:43Z
format Article
id doaj.art-56d760feecc147b8bc63c58832b4530b
institution Directory Open Access Journal
issn 2297-055X
language English
last_indexed 2024-12-17T10:23:43Z
publishDate 2021-10-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cardiovascular Medicine
spelling doaj.art-56d760feecc147b8bc63c58832b4530b2022-12-21T21:52:43ZengFrontiers Media S.A.Frontiers in Cardiovascular Medicine2297-055X2021-10-01810.3389/fcvm.2021.750670750670Body Mass Index and Long-Term Follow-Up Outcomes in Patients With Acute Myocardial Infarction by the Median of Non-HDL Cholesterol: Results From an Observational Cohort Study in ChinaHui Gao0Aidong Shen1Hui Chen2Hongwei Li3Hongwei Li4Hongwei Li5Department of Cardiology, Cardiovascular Center, Beijing Friendship Hospital, Capital Medical University, Beijing, ChinaDepartment of Cardiology, Cardiovascular Center, Beijing Friendship Hospital, Capital Medical University, Beijing, ChinaDepartment of Cardiology, Cardiovascular Center, Beijing Friendship Hospital, Capital Medical University, Beijing, ChinaDepartment of Cardiology, Cardiovascular Center, Beijing Friendship Hospital, Capital Medical University, Beijing, ChinaDepartment of Internal Medical, Medical Health Center, Beijing Friendship Hospital, Capital Medical University, Beijing, ChinaBeijing Key Laboratory of Metabolic Disorder Related Cardiovascular Disease, Beijing, ChinaBackground: The association between obesity, non-HDL cholesterol, and clinical outcomes in subjects with acute myocardial infarction (AMI) undergoing percutaneous coronary intervention (PCI) is incompletely understood. The aim of this investigation was to explore the association between body mass index (BMI), non-high density lipoprotein (non-HDL) cholesterol, and long-term follow-up prognosis.Methods: This present study used data obtained by the Cardiovascular Center of Beijing Friendship Hospital Database Bank. We identified 3,780 consecutive AMI populations aged 25–93 years from 2013 to 2020. Participants were categorized as normal weight (18.5 ≤ BMI <22.9 kg/m2), overweight (23.0 ≤ BMI <24.9 kg/m2), obese class I (25.0 ≤ BMI <29.9 kg/m2), and obese class II (BMI ≥ 30.0 kg/m2). The endpoint of interest was cardiovascular (CV) death, all-cause death, myocardial infarction (MI), stroke, unplanned revascularization, and cardiac hospitalization.Results:Participants with higher BMI were younger and more likely to be males compared with lower BMI groups. Elevated non-HDL cholesterol was present in 8.7, 11.0, 24.3, and 5.9% of the normal, overweight, obese class I, and obese class II groups, respectively. After multivariate adjustment, compared to normal-weight participants with decreased non-HDL cholesterol (reference group), obese participants with and without elevated non-HDL cholesterol had a lower risk of mortality (with obese class I and elevated non-HDL cholesterol: hazard ratio [HR] 0.44, 95% confidence interval [CI] 0.28–0.67; with obese class I and decreased non-HDL cholesterol: HR, 0.68, 95% CI, 0.47–0.98; with obese class II and elevated non-HDL cholesterol: HR, 0.42, 95% CI, 0.20–0.87; with obese class II and decreased non-HDL cholesterol: HR, 0.35, 95% CI, 0.16–0.72).Conclusion: In AMI participants performing with PCI, obesity had a better long-term prognosis which probably unaffected by the level of non-HDL cholesterol.https://www.frontiersin.org/articles/10.3389/fcvm.2021.750670/fullobesityobesity paradoxnon-HDL cholesterolacute myocardial infarctionoutcomes
spellingShingle Hui Gao
Aidong Shen
Hui Chen
Hongwei Li
Hongwei Li
Hongwei Li
Body Mass Index and Long-Term Follow-Up Outcomes in Patients With Acute Myocardial Infarction by the Median of Non-HDL Cholesterol: Results From an Observational Cohort Study in China
Frontiers in Cardiovascular Medicine
obesity
obesity paradox
non-HDL cholesterol
acute myocardial infarction
outcomes
title Body Mass Index and Long-Term Follow-Up Outcomes in Patients With Acute Myocardial Infarction by the Median of Non-HDL Cholesterol: Results From an Observational Cohort Study in China
title_full Body Mass Index and Long-Term Follow-Up Outcomes in Patients With Acute Myocardial Infarction by the Median of Non-HDL Cholesterol: Results From an Observational Cohort Study in China
title_fullStr Body Mass Index and Long-Term Follow-Up Outcomes in Patients With Acute Myocardial Infarction by the Median of Non-HDL Cholesterol: Results From an Observational Cohort Study in China
title_full_unstemmed Body Mass Index and Long-Term Follow-Up Outcomes in Patients With Acute Myocardial Infarction by the Median of Non-HDL Cholesterol: Results From an Observational Cohort Study in China
title_short Body Mass Index and Long-Term Follow-Up Outcomes in Patients With Acute Myocardial Infarction by the Median of Non-HDL Cholesterol: Results From an Observational Cohort Study in China
title_sort body mass index and long term follow up outcomes in patients with acute myocardial infarction by the median of non hdl cholesterol results from an observational cohort study in china
topic obesity
obesity paradox
non-HDL cholesterol
acute myocardial infarction
outcomes
url https://www.frontiersin.org/articles/10.3389/fcvm.2021.750670/full
work_keys_str_mv AT huigao bodymassindexandlongtermfollowupoutcomesinpatientswithacutemyocardialinfarctionbythemedianofnonhdlcholesterolresultsfromanobservationalcohortstudyinchina
AT aidongshen bodymassindexandlongtermfollowupoutcomesinpatientswithacutemyocardialinfarctionbythemedianofnonhdlcholesterolresultsfromanobservationalcohortstudyinchina
AT huichen bodymassindexandlongtermfollowupoutcomesinpatientswithacutemyocardialinfarctionbythemedianofnonhdlcholesterolresultsfromanobservationalcohortstudyinchina
AT hongweili bodymassindexandlongtermfollowupoutcomesinpatientswithacutemyocardialinfarctionbythemedianofnonhdlcholesterolresultsfromanobservationalcohortstudyinchina
AT hongweili bodymassindexandlongtermfollowupoutcomesinpatientswithacutemyocardialinfarctionbythemedianofnonhdlcholesterolresultsfromanobservationalcohortstudyinchina
AT hongweili bodymassindexandlongtermfollowupoutcomesinpatientswithacutemyocardialinfarctionbythemedianofnonhdlcholesterolresultsfromanobservationalcohortstudyinchina